Director Sam Samad (NASDAQ: IDXX) receives new stock units and options grant

Rhea-AI Filing Summary

IDEXX Laboratories director Sam Samad received new equity awards as part of his board compensation. On May 12, 2026, he was granted 234 deferred stock units, each representing a right to one share of common stock, bringing his deferred stock unit balance to 1,354 units. He also received a non-qualified stock option for 525 shares of common stock at an exercise price of $533.92 per share, with 525 options reported as held after the grant. Both the option and deferred stock units vest in a single installment on the one-year anniversary of the grant date or on the date of the 2027 annual meeting of shareholders, whichever occurs first. The deferred stock units are, by default, payable in common stock after his resignation from the board.

Insights

Equity Compensation Analyst

Routine director equity grants with future-vesting options and stock units.

Sam Samad, a director of IDEXX Laboratories, received equity awards rather than transacting in the open market. The Form 4 shows grants of deferred stock units and non-qualified stock options, which are standard tools to align director incentives with long-term shareholder interests.

The grant includes 234 deferred stock units and a stock option over 525 shares at an exercise price of $533.92, expiring in 2036. Both awards vest on the earlier of the one-year anniversary of grant or the 2027 annual shareholder meeting, so the value depends on his continued service.

The filing reports 1,354 deferred stock units and 525 options held after these awards. No sales or exercises occurred, so there is no immediate cash impact or market signal; this is a routine compensation event rather than a directional bet on the stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider SAMAD SAM

Role null

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right-to-buy)	525	$0.00	--
Grant/Award	Deferred Stock Unit	234	$0.00	--

Holdings After Transaction: Non-Qualified Stock Option (right-to-buy) — 525 shares (Direct, null); Deferred Stock Unit — 1,354 shares (Direct, null)

Footnotes (1)

1. Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.

Key Figures

Deferred stock units granted: 234 units Deferred stock units held after grant: 1,354 units Stock options granted: 525 options +2 more

5 metrics

Deferred stock units granted 234 units Grant on May 12, 2026 to director Sam Samad

Deferred stock units held after grant 1,354 units Reported balance following May 12, 2026 award

Stock options granted 525 options Non-qualified stock option awarded May 12, 2026

Option exercise price $533.92 per share Exercise price for 525-share non-qualified option

Option expiration May 11, 2036 Expiration date of non-qualified stock option grant

Key Terms

Deferred Stock Unit, Non-Qualified Stock Option (right-to-buy), contingent right, annual meeting of shareholders, +1 more

5 terms

Deferred Stock Unit financial

"Each deferred stock unit represents a contingent right to receive one share of Issuer common stock."

A deferred stock unit (DSU) is a promise from a company to give an employee or director the value of a share at a future date, paid in actual shares or cash when certain conditions are met (such as retirement or a set date). Think of it like a gift card that converts to company stock later; it aligns pay with long‑term performance and can affect future share count, compensation expense and potential cash needs, so investors watch DSUs for their impact on dilution and company finances.

Non-Qualified Stock Option (right-to-buy) financial

"Non-Qualified Stock Option (right-to-buy)"

contingent right financial

"Each deferred stock unit represents a contingent right to receive one share of Issuer common stock."

annual meeting of shareholders financial

"on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Board of Directors financial

"following the date of the Director's resignation from the Board of Directors."

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SAMAD SAM

(Last) (First) (Middle)

ONE IDEXX DRIVE

(Street)

WESTBROOK MAINE 04092

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right-to-buy)	$533.92	05/12/2026		A		525		(1)	05/11/2036	Common Stock	525	$0	525	D
Deferred Stock Unit	(2)	05/12/2026		A		234		(2)	(2)	Common Stock	234	$0	1,354	D

Explanation of Responses:

1. Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.

2. Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.

Remarks:

	/s/ Lily J. Lu, Attorney-in-Fact for Sam Samad	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did IDXX director Sam Samad receive in this Form 4?

Sam Samad received two equity awards: 234 deferred stock units and a non-qualified stock option for 525 shares. These awards are part of his director compensation and provide future exposure to IDEXX Laboratories common stock, subject to vesting conditions.

What is the exercise price and expiration date of Sam Samad’s new IDXX stock options?

The non-qualified stock option granted to Sam Samad covers 525 shares at an exercise price of $533.92 per share. The option expires on May 11, 2036, giving him a long window to decide whether to exercise, assuming vesting conditions are met.

How and when do Sam Samad’s IDEXX deferred stock units vest and pay out?

The 234 deferred stock units vest in one installment on the earlier of the one-year anniversary of grant or the 2027 annual shareholder meeting. By default, they are payable as common stock after Samad resigns from the Board, providing long-term, service-based compensation.

Did Sam Samad buy or sell any IDEXX common stock in this Form 4?

No open-market buys or sells are reported. The Form 4 only shows acquisitions via grants: deferred stock units and a non-qualified stock option. These are compensation awards, not market trades, so they do not indicate a change in his trading stance.

What are Sam Samad’s reported holdings after these IDXX equity grants?

After the grants, Sam Samad is reported holding 1,354 deferred stock units and 525 non-qualified stock options linked to IDEXX common stock. These positions reflect his equity-based director compensation and will only deliver value if vesting occurs and the stock performs.

Are Sam Samad’s new IDXX equity awards contingent on continued board service?

Yes. Both the 234 deferred stock units and 525 stock options vest in a single installment on the earlier of one year from grant or the 2027 annual meeting. This structure ties the awards to ongoing board service and long-term company performance.